Insider track record Other Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Maya Martinez-Davis. Insider active across 1 company, notably GSK plc. Aggregated, 26 reports have been recorded. History available since 9 February 2026. The latest transaction was disclosed on 12 February 2026 (A conditional award of ADS under the Company's 2017 Performa). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 26 total
● President, US · Executives · 7 Jul 2026 · GSK plc 0
US37733W2044⌘ RNS:9661747 Ideal exit: 3 Apr 2027 (T+270) ● President, US · Executives · 7 Jul 2026 · GSK plc 0
US37733W2044⌘ RNS:289d903e-7ee1-4fa9-bcbd-3a43dc019bc2 Ideal exit: 3 Apr 2027 (T+270) ● President, US · Executives · 22 Jun 2026 · GSK plc 0
US37733W2044⌘ RNS:9635096 Ideal exit: 19 Mar 2027 (T+270) ● President, US · Executives · 22 Jun 2026 · GSK plc 0
US37733W2044⌘ RNS:f96aec1d-517b-42fe-998e-999eab24c64e Ideal exit: 19 Mar 2027 (T+270) ● President, US · Executives · 8 Jun 2026 · GSK plc 0
US37733W2044⌘ RNS:9612073 Ideal exit: 5 Mar 2027 (T+270) ● President, US · Executives · 8 Jun 2026 · GSK plc 0
US37733W2044⌘ RNS:c5a93bfc-97ef-49a5-bcc4-05857b3c3b90 Ideal exit: 5 Mar 2027 (T+270) ● President, US · Executives · 22 May 2026 · GSK plc 0
US37733W2044⌘ RNS:9588311 Ideal exit: 16 Feb 2027 (T+270) ● President, US · Executives · 22 May 2026 · GSK plc 0
US37733W2044⌘ RNS:75c0e8d5-7c01-408c-a26c-84c6611b8f73 Ideal exit: 16 Feb 2027 (T+270) ● President, US · Executives · 15 May 2026 · GSK plc 0
US37733W2044⌘ RNS:9576175-2 Ideal exit: 9 Feb 2027 (T+270) ● President, US · Executives · 15 May 2026 · GSK plc 0
US37733W2044⌘ RNS:0c2b3473-feab-43c0-81c0-8a4af4e4f91f-2 Ideal exit: 9 Feb 2027 (T+270) ● President, US · Executives · 7 May 2026 · GSK plc 0
US37733W2044⌘ RNS:2a6a278d-267e-49ac-b714-020088a48904 Ideal exit: 1 Feb 2027 (T+270) ● President, US · Executives · 22 Apr 2026 · GSK plc 0
US37733W2044⌘ RNS:d5dec057-3334-4101-a527-1f9a20145e3c Ideal exit: 17 Jan 2027 (T+270) ● President, US · Executives · 14 Apr 2026 · GSK plc 0
US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-18 Ideal exit: 9 Jan 2027 (T+270) ● President, US · Executives · 14 Apr 2026 · GSK plc 0
US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-19 Ideal exit: 9 Jan 2027 (T+270) ● President, US · Executives · 7 Apr 2026 · GSK plc 0
US37733W2044⌘ RNS:e48c2f19-f550-4e43-bacf-e5379f6d6b51 Ideal exit: 2 Jan 2027 (T+270) ● President, US · Executives · 23 Mar 2026 · GSK plc 0
US37733W2044⌘ RNS:0a1152a8-d690-40e8-bef2-2b869d712c3f Ideal exit: 18 Dec 2026 (T+270) ● President, US · Executives · 13 Mar 2026 · GSK plc 0
US37733W2044⌘ RNS:a9ad7e9f-8439-4151-8c1a-69008fbc3c27 Ideal exit: 8 Dec 2026 (T+270) ● President, US · Executives · 9 Mar 2026 · GSK plc 0
US37733W2044⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-9 Ideal exit: 4 Dec 2026 (T+270) ● President, US · Executives · 20 Feb 2026 · GSK plc 0
US37733W2044⌘ RNS:5828e747-31e9-4d32-b844-dd5ef59cb57b Ideal exit: 17 Nov 2026 (T+270) ● President, US · Executives · 13 Feb 2026 · GSK plc 42,631 shares 0
US37733W2044⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-10 ● President, US · Executives · 13 Feb 2026 · GSK plc 0
US37733W2044⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-11 ● President, US · Executives · 13 Feb 2026 · GSK plc 0
US37733W2044⌘ RNS:cd586599-5aa9-4f96-8ae0-260d3668550c-0 ● President, US · Executives · 13 Feb 2026 · GSK plc 0
US37733W2044⌘ RNS:cd586599-5aa9-4f96-8ae0-260d3668550c-1 ● President, US · Executives · 12 Feb 2026 · GSK plc 53,433 shares @ £0.5849 95.0% of flow US37733W2044⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-6 ● President, US · Executives · 9 Feb 2026 · GSK plc 10,658 shares 0
US37733W2044⌘ RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-4 25 of 26 declarations
Load more (1 remaining) About Maya Martinez-Davis Maya Martinez-Davis has filed 24 filings, all with GSK plc, where she holds the position of President, US. Between February 11, 2026, and June 25, 2026, she executed transactions totaling 1896 euros in sales, with an amount of 1895.83 euros recorded on February 11, 2026. She also made a purchase amounting to 35849.02 euros on February 16, 2026.